Provided by Tiger Trade Technology Pte. Ltd.

Cellectar Biosciences, Inc. Series A Warrants

0.1190
0.0000
Volume:- -
Turnover:- -
Market Cap:- -
PE:- -
High:0.1190
Open:0.1190
Low:0.1190
Close:0.1190
52wk High:0.1900
52wk Low:0.0225
Shares:- -
Float Shares:- -
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Jun 04, 2021

Major Issues Report

8-K - Current report
May 20, 2021

Major Issues Report

8-K - Current report
May 14, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
May 03, 2021

Major Issues Report

8-K - Current report
Apr 30, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 27, 2021

Major Issues Report

8-K - Current report
Apr 16, 2021

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Mar 11, 2021

Major Issues Report

8-K - Current report
Mar 09, 2021

Major Issues Report

8-K - Current report
Mar 05, 2021

Major Issues Report

8-K - Current report
Mar 02, 2021

Major Issues Report

8-K - Current report
Mar 02, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 17, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals